Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


2nd Reverse Phase Protein Array Global Workshop

12 Nov 2012 - 13 Nov 2012 - Edinburgh, Scotland, UK



Bookmark and Share


Key Workstreams;

  • Challenges, needs, advantages and disadvantages associated with printing and detection
  • Image acquisition, data processing and normalization
  • Validating and sharing of Antibody data
  • Alignment with "Proteomics Standard Initiative" (PSI) at HUPO
  • New technologies showcase
  • Pharmaceutical Discovery applications
  • RPPA in management and analysis of clinical samples
  • How to use RPA Data in the Clinic (i.e. PD Marker, Prognostic Marker and Predictive Marker):
  • Launch : Global RPPA Society


The evolution of Reverse Phase Protein Array (RPPA ) technologies has facilitated the application of high-throughput functional proteomics in patient samples and preclinical drug screening with improved sensitivity and quantification to support the identification and analysis of post-translational biomarkers and pathway networks.

Advancing RPPA technology into mainstream basic research, drug discovery and clinical diagnostics applications will require improved consistency in methods and an expanded portfolio of validated antibody reagents and procedures that can be shared across the community.

Hosted by the University of Edinburgh, the second Reverse Phase Protein Array Global Workshop will bring together scientists from both academia and industry to discuss the latest technical advances and standards for generating and analysing results using Reverse Phase Protein Arrays.

The 2012 workshop shall also be used to launch a global RPPA society to support communication, data-sharing and ambitions of the RPPA community.



Further information
Scientific News
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
Self-Assembling Protein Shell for Drug Delivery
Made-to-order nano-cages open possibilities of shipping cargo into living cells or fashioning small chemical reactors.
Fighting Resistant Blood Cancer Cells
Biologists present new findings on chronic myeloid leukemia and possible therapeutic approaches.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
Guided Chemotherapy Missiles
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Biomarkers That Could Help Give Cancer Patients Better Survival Estimates Discovered
UCLA research may also help scientists suppress dangerous genetic sequences.
Body’s Own Gene Editing System Generates Leukemia Stem Cells
Inhibiting the editing enzyme may provide a new therapeutic approach for blood cancers.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!